Yasuko Kai
About
In The Last Decade
Yasuko Kai
8 papers receiving 367 citations
Peers
Comparison fields: 5 of 76
- Molecular Biology 146
- Pathology and Forensic Medicine 135
- Biochemistry 76
- Psychiatry and Mental health 48
- Oncology 44
Countries citing papers authored by Yasuko Kai
This map shows the geographic impact of Yasuko Kai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasuko Kai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasuko Kai more than expected).
Fields of papers citing papers by Yasuko Kai
This network shows the impact of papers produced by Yasuko Kai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasuko Kai. The network helps show where Yasuko Kai may publish in the future.
Co-authorship network of co-authors of Yasuko Kai
This figure shows the co-authorship network connecting the top 25 collaborators of Yasuko Kai. A scholar is included among the top collaborators of Yasuko Kai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasuko Kai. Yasuko Kai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 18 | |
| 3 | 5 | |
| 4 | Synergistic effects of (--)-epigallocatechin gallate with (--)-epicatechin, sulindac, or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9. | 202 |
| 5 | Heterogeneous nuclear ribonucleoprotein B1 as a new marker of early detection for human lung cancers. | 88 |
| 6 | 54 | |
| 7 | 3 | |
| 8 | 5 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.